Thurm Christoph, Poltorak Mateusz P, Reimer Elisa, Brinkmann Melanie M, Leichert Lars, Schraven Burkhart, Simeoni Luca
Institute of Molecular and Clinical Immunology, Health Campus Immunology, Infectiology, and Inflammation, Otto von Guericke University, Magdeburg, Germany.
Current address: Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, Technische Universität München, Munich, Germany.
Oncotarget. 2017 May 9;8(19):30805-30816. doi: 10.18632/oncotarget.16486.
ζ-associated protein of 70 kDa (Zap70) is crucial for T-cell receptor (TCR) signaling. Loss of Zap70 in both humans and mice results in severe immunodeficiency. On the other hand, the expression of Zap70 in B-cell malignancies correlates with the severity of the disease. Because of its role in immune-related disorders, Zap70 has become a therapeutic target for the treatment of human diseases. It is well-established that the activity/expression of Zap70 is regulated by post-translational modifications of crucial amino acids including the phosphorylation of tyrosines and the ubiquitination of lysines. Here, we have investigated whether also oxidation of cysteine residues regulates Zap70 functions. We have identified C575 as a major sulfenylation site of Zap70. A C575A substitution results in protein instability, reduced activity, and increased dependency on the Hsp90/Cdc37 chaperone system. Indeed, Cdc37 overexpression reconstituted partially the expression but fully the function of Zap70C575A. C575 lies within a Mx(2)CWx(6)R motif which is highly conserved among almost all human tyrosine kinases. Mutation of any of the conserved amino acids, but not of a non-conserved residue preceding the cysteine, also results in Zap70 instability. Collectively, we have identified a new redox-active motif which is crucial for the regulation of Zap70 stability/activity. We believe that this motif has the potential to become a novel target for the development of therapeutic tools to modulate the expression/activity of kinases.
70 kDa的ζ相关蛋白(Zap70)对T细胞受体(TCR)信号传导至关重要。人类和小鼠体内Zap70的缺失都会导致严重的免疫缺陷。另一方面,Zap70在B细胞恶性肿瘤中的表达与疾病的严重程度相关。由于其在免疫相关疾病中的作用,Zap70已成为治疗人类疾病的一个治疗靶点。众所周知,Zap70的活性/表达受关键氨基酸的翻译后修饰调控,包括酪氨酸的磷酸化和赖氨酸的泛素化。在此,我们研究了半胱氨酸残基的氧化是否也调节Zap70的功能。我们已确定C575是Zap70的主要亚磺酰化位点。C575A替换导致蛋白质不稳定、活性降低以及对Hsp90/Cdc37伴侣系统的依赖性增加。事实上,Cdc37的过表达部分恢复了Zap70C575A的表达,但完全恢复了其功能。C575位于一个Mx(2)CWx(6)R基序内,该基序在几乎所有人类酪氨酸激酶中高度保守。任何保守氨基酸的突变,而非半胱氨酸之前的非保守残基的突变,也会导致Zap70不稳定。总体而言,我们已鉴定出一个新的氧化还原活性基序,它对Zap70稳定性/活性的调节至关重要。我们认为这个基序有潜力成为开发调节激酶表达/活性的治疗工具的新靶点。